# Safety and Efficacy of HB-1 for Panic Disorder

> **NCT05071430** · PHASE2 · COMPLETED · sponsor: **HB BioTech, LLC** · enrollment: 86 (actual)

## Conditions studied

- Panic Disorder

## Interventions

- **DRUG:** HB-01
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05071430
- **Lead sponsor:** HB BioTech, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-03
- **Primary completion:** 2022-12-12
- **Final completion:** 2022-12-12
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2025-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05071430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05071430, "Safety and Efficacy of HB-1 for Panic Disorder". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05071430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*